Anti-Human CD262 Recombinant Antibody(Tigatuzumab)

Product Information

Catalog Number	YR1151
Product Name	Anti-Human CD262 Recombinant Antibody(Tigatuzumab)
Molecular Name	Tigatuzumab
Alias	Anti-CD262 Recombinant Antibody, Research Grade Tigatuzumab
CAS Number	918127-53-4
Target	CD262[Homo sapiens]
Isotype	IgG1
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	IF, IP, Neut, FuncS, ELISA, FCM
Buffer	PBS, pH7.5
Background	Tigatuzumab (CS-1008) is a monoclonal antibod for the treatment of cancer. As of October 2009, a clinical trial for the treatment of pancreatic cancer, Phase II trials for colorectal cancer, non-small cell lung cancer, and ovarian cancer have been completed.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price